Erin Quirk
Presidente en TERNS PHARMACEUTICALS, INC. .
Fortuna: 348 000 $ al 30/04/2024
Perfil
Erin Quirk is currently the President and Head of Research & Development at Terns Pharmaceuticals, Inc. Prior to this, Dr. Quirk worked at Gilead Sciences, Inc. as the Vice President of HIV Clinical Research from 2010 to 2018.
Dr. Quirk completed their undergraduate degree at Drew University and their graduate degree at The University of Colorado.
They also obtained a doctorate degree from The University of Colorado School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/01/2024 | 75 000 ( 0.12% ) | 348 000 $ | 30/04/2024 |
Cargos activos de Erin Quirk
| Empresas | Cargo | Inicio |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Presidente | 07/02/2024 |
Antiguos cargos conocidos de Erin Quirk.
| Empresas | Cargo | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/09/2018 |
Formación de Erin Quirk.
| Drew University | Undergraduate Degree |
| The University of Colorado School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Erin Quirk
